HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

lorcaserin

orally active, small-molecule 5-hydroxytryptamine 2C agonist for the potential treatment of obesity and diabetes
Also Known As:
(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine; 8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine; APD 356; APD-356; APD356; AR-10A; Belviq
Networked: 260 relevant articles (46 outcomes, 74 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Higgins, Guy A: 13 articles (01/2020 - 04/2012)
2. Fletcher, Paul J: 12 articles (01/2021 - 04/2012)
3. Smith, Steven R: 12 articles (01/2019 - 03/2009)
4. Shanahan, William R: 8 articles (01/2020 - 03/2009)
5. Fain, Randi: 8 articles (01/2017 - 10/2014)
6. Aronne, Louis J: 7 articles (01/2019 - 01/2015)
7. Shanahan, William: 7 articles (04/2017 - 10/2014)
8. France, Charles P: 6 articles (10/2021 - 12/2015)
9. Wiviott, Stephen D: 6 articles (01/2019 - 11/2014)
10. Sanchez, Matilde: 6 articles (04/2017 - 07/2010)

Related Diseases

1. Weight Loss (Weight Reduction)
2. Obesity
3. Overweight
4. Type 2 Diabetes Mellitus (MODY)
5. Body Weight (Weight, Body)

Related Drugs and Biologics

1. Phentermine (Adipex-P)
2. Topiramate (Topamax)
3. 5-HT2C Serotonin Receptor
4. Orlistat (Xenical)
5. Liraglutide
6. Naltrexone (ReVia)
7. Bupropion (Wellbutrin)
8. Serotonin (5 Hydroxytryptamine)
9. lorcaserin
10. Anti-Obesity Agents (Antiobesity Drugs)

Related Therapies and Procedures

1. Therapeutics
2. Glycemic Control
3. Caloric Restriction
4. Tobacco Use Cessation Devices
5. Obesity Management